Adocia S.A [ADOC] vs Abivax SA [ABVX] Detailed Stock Comparison

Adocia S.A

Euronext
Loading...

Abivax SA

Euronext
Loading...

TLDR: Quick Comparison Summary

Based on 18 vital metrics comparison: Adocia S.A wins in 9 metrics, Abivax SA wins in 8 metrics, with 0 ties. Adocia S.A appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricAdocia S.AAbivax SABetter
P/E Ratio (TTM)-8.38-24.79Abivax SA
Price-to-Book Ratio-38.22-91.19Abivax SA
Debt-to-Equity Ratio-3.83-2.04Adocia S.A
PEG Ratio-6.30-47.21Abivax SA
EV/EBITDA-22.51-24.20Abivax SA
Profit Margin (TTM)-76.88%0.00%Abivax SA
Operating Margin (TTM)8.14%-4,440.88%Adocia S.A
EBITDA Margin (TTM)8.14%N/AN/A
Return on Equity301.75%-499.78%Adocia S.A
Return on Assets (TTM)-17.81%-57.74%Adocia S.A
Free Cash Flow (TTM)$-15.84M$-154.72MAdocia S.A
1-Year Return35.42%590.57%Abivax SA
Price-to-Sales Ratio (TTM)12.63892.23Adocia S.A
Enterprise Value$155.48M$4.49BAbivax SA
EV/Revenue Ratio12.82746.06Adocia S.A
Revenue per Share (TTM)$1$0Adocia S.A
Earnings per Share (Diluted)$-1.00$-3.09Adocia S.A
Beta (Stock Volatility)0.350.13Abivax SA
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Adocia S.A vs Abivax SA Stock Performance Analysis

Loading Price Chart...

Adocia S.A
Abivax SA
Adocia S.A Stock Overview | Abivax SA Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Adocia S.A-6.92%-1.14%-12.26%119.10%85.71%21.31%
Abivax SA1.30%2.48%7.49%1,257.14%926.28%865.66%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Adocia S.A35.42%140.74%6.85%-89.72%-17.02%-17.02%
Abivax SA590.57%784.28%273.14%270.00%239.61%239.61%

News Based Sentiment: Adocia S.A vs Abivax SA

Adocia S.A

News based Sentiment: MIXED

September presented a mixed bag for Adocia, with positive analyst sentiment countered by stock volatility and negative technical indicators. The upcoming earnings release and data presentations are key catalysts, but the overall picture remains uncertain, making it a significant month for investors to assess the company's trajectory.

View Adocia S.A News Sentiment Analysis

Abivax SA

News based Sentiment: POSITIVE

September was a strong month for Abivax, marked by positive Phase 3 trial results for obefazimod, a successful capital raise earlier in the year, and growing institutional investment. These developments led to increased analyst confidence, a surge in stock price, and inclusion in major indices, signaling a positive trajectory for the company.

View Abivax SA News Sentiment Analysis

Performance & Financial Health Analysis: Adocia S.A vs Abivax SA

MetricADOCABVX
Market Information
Market Cap i€153.13M€5.37B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i237,346137,280
90 Day Avg. Volume i492,33293,960
Last Close€7.80€70.30
52 Week Range€2.86 - €11.10€4.51 - €78.70
% from 52W High-29.73%-10.67%
All-Time High€94.24 (Jul 20, 2015)€78.70 (Sep 08, 2025)
% from All-Time High-91.72%-10.67%
Growth Metrics
Quarterly Revenue Growth3.97%-0.81%
Quarterly Earnings GrowthN/AN/A
Financial Health
Profit Margin (TTM) i-0.77%0.00%
Operating Margin (TTM) i0.08%-44.41%
Return on Equity (TTM) i3.02%-5.00%
Debt to Equity (MRQ) i-3.83-2.04
Cash & Liquidity
Book Value per Share (MRQ)€-0.20€-0.76
Cash per Share (MRQ)€0.42€0.96
Operating Cash Flow (TTM) i€-15,612,000€-135,515,008
Levered Free Cash Flow (TTM) i€-11,774,125€-88,009,752
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Adocia S.A vs Abivax SA

MetricADOCABVX
Price Ratios
P/E Ratio (TTM) i-8.38-24.79
Forward P/E i-6.30-47.21
PEG Ratio i-6.30-47.21
Price to Sales (TTM) i12.63892.23
Price to Book (MRQ) i-38.22-91.19
Market Capitalization
Market Capitalization i€153.13M€5.37B
Enterprise Value i€155.48M€4.49B
Enterprise Value Metrics
Enterprise to Revenue i12.82746.06
Enterprise to EBITDA i-22.51-24.20
Risk & Other Metrics
Beta i0.350.13
Book Value per Share (MRQ) i€-0.20€-0.76

Financial Statements Comparison: Adocia S.A vs Abivax SA

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)ADOCABVX
Revenue/Sales iN/A€0
Cost of Goods Sold iN/AN/A
Gross Profit iN/AN/A
Research & Development iN/A€38.65M
Operating Income (EBIT) iN/A€-46.50M
EBITDA iN/A€-43.02M
Pre-Tax Income iN/A€-48.41M
Income Tax iN/A€0
Net Income (Profit) iN/A€-48.41M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)ADOCABVX
Cash & Equivalents i€7.53M€103.58M
Total Current Assets i€22.45M€132.67M
Total Current Liabilities i€20.85M€105.74M
Long-Term Debt i€8.57M€48.19M
Total Shareholders Equity i€-3.09M€-6.59M
Retained Earnings i€-9.32M€-486.52M
Property, Plant & Equipment i€3.78M€484,000

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)ADOCABVX
Operating Cash Flow iN/A€-31.76M
Capital Expenditures iN/A€-44,000
Free Cash Flow iN/A€-33.32M
Debt Repayment iN/A€-6.12M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricADOCABVX
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i237,346137,280
Average Daily Volume (90 Day) i492,33293,960
Shares Outstanding i15.63M63.35M
Float Shares i14.26M34.26M
% Held by Insiders i0.21%0.01%
% Held by Institutions i0.08%0.48%

Dividend Analysis & Yield Comparison: Adocia S.A vs Abivax SA

MetricADOCABVX
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A